Northern Oak Wealth Management Inc Moderna, Inc. Transaction History

Northern Oak Wealth Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 24, 2022	SELL	$126.46 - $235.05 $1,896 - $3,525	-15 Reduced 17.65%	70 $12,000
Q4 2021 Feb 16, 2022	SELL	$225.82 - $368.51 $132,104 - $215,578	-585 Reduced 87.31%	85 $22,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $1.16 Million - $2.54 Million	-5,249 Reduced 88.68%	670 $258,000
Q2 2021 Aug 17, 2021	BUY	$129.91 - $234.98 $596,806 - $1.08 Million	4,594 Added 346.72%	5,919 $1.39 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $71,512 - $121,816	655 Added 97.76%	1,325 $174,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $39,444 - $101,916	600 Added 857.14%	670 $70,000
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $3,803 - $6,639	70 New	70 $5,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Northern Oak Wealth Management Inc, based on Form 13F filings with the SEC.

Stay updated on Northern Oak Wealth Management Inc with notifications on news.